Risk Management

3rd Edition of “ROP: Creating a Safety Net” Published

OMIC ROP Safety Net revised in 2022 to reflect changes to International Classification of Retinopathy of Prematurity, Third Edition (ICROP3).

Click on the name of the document to access it. 

Clinical Tables Revised with Changes Highlighted

ROP Risk Analysis 

ROP Conditions of Coverage

ROP Risk Management Recommendations for AntiVEGF

ROP Tracking List


Hospital toolkit.Treat at hospital

Hospital toolkit.Transfer to treat


The Office toolkit has additional procedures, forms, and letters needed for outpatient care.


The following consent forms and letters are in the toolkits and procedures, but can also be accessed directly:

Consent: ROP Injection to treat

Consent: ROP Laser Surgery to Treat


Discharge letter

Missed appointment letter

Outpatient screening letter

Transfer for other care letter

Transfer to treat

Please refer to OMIC's Copyright and Disclaimer regarding the contents on this website

Leave a comment

Six reasons OMIC is the best choice for ophthalmologists in America.

Best at defending claims.

An ophthalmologist pays nearly half a million dollars in premiums over the course of a career. Premium paid is directly related to a carrier’s claims experience. OMIC has a higher win rate taking tough cases to trial, full consent to settle (no hammer) clause, and access to the best experts. OMIC pays 25% less per claim than other carriers. As a result, OMIC has consistently maintained lower base rates than multispecialty carriers in the U.S.